Published • loading... • Updated
EnteroBiotix Completes Enrolment in Phase IIa MAST Trial
Summary by Clinical Trials Arena
2 Articles
2 Articles
EnteroBiotix completes enrolment in Phase IIa MAST trial
EnteroBiotix has completed enrolment in the Phase IIa MAST trial of EBX-102-02 in patients undergoing allo-HSCT for haematological malignancies.The post EnteroBiotix completes enrolment in Phase IIa MAST trial appeared first on Clinical Trials Arena.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
